PTSD - Post Traumatic Stress Disorder study: COMP360 psilocybin
Official title Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
ClinicalTrials.gov ID: NCT07570654
What this study is testing
What is COMP360 psilocybin?
This is an investigational medicine being studied to see if it may help reduce symptoms of PTSD. It is designed to interact with brain receptors to affect mood and thinking, similar to other psilocybin compounds.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether COMP360 can reduce PTSD symptoms. It also checks how safe the drug is and what side effects it causes.
- Who it's for
- You may be able to join if you have post-traumatic stress disorder (PTSD).
- What's involved
- You would take COMP360, a lab-made form of psilocybin. A trained team would monitor you and provide support.
- Time commitment
- The source text does not say how long the study lasts or what visits are needed.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older
- Diagnosed with PTSD at least 6 months ago
You likely can't join if
- \- Diagnosed with certain psychiatric conditions such as bipolar disorder, schizophrenia, OCD, anorexia, or other conditions
The study team makes the final eligibility decision.
Where it is enrolling
- Tucson, Arizona, United States
- Irvine, California, United States
- Los Angeles, California, United States
- Moorpark, California, United States
- San Jose, California, United States
- Miami, Florida, United States
- Orlando, Florida, United States
- Chicago, Illinois, United States
- Boston, Massachusetts, United States
- Eden Prairie, Minnesota, United States
- Lincoln, Nebraska, United States
- Las Vegas, Nevada, United States
- New York, New York, United States
- The Bronx, New York, United States
- North Canton, Ohio, United States
- Carrollton, Texas, United States
- Orem, Utah, United States
- Kamloops, British Columbia, Canada
- North Vancouver, British Columbia, Canada
- Penticton, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Tucson, Arizona, United States; Irvine, California, United States; Los Angeles, California, United States; Moorpark, California, United States; San Jose, California, United States; Miami, Florida, United States and 14 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.